The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
Open accessAbstract
The Concise Guide to PHARMACOLOGY 2021/22 is the fifth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of nearly 1900 human drug targets with an emphasis on selective pharmacology (where available), plus links to the open access knowledgebase source of drug targets and their ligands (www.guidetopharmacology.org), which provides more detailed views of target and ligand properties. Although the Concise Guide constitutes over 500 pages, the material presented is substantially reduced compared to information and links presented on the website. It provides a permanent, citable, point‐in‐time record that will survive database updates. The full contents of this section can be found at http://onlinelibrary.wiley.com/doi/bph.15538. G protein‐coupled receptors are one of the six major pharmacological targets into which the Guide is divided, with the others being: ion channels, nuclear hormone receptors, catalytic receptors, enzymes and transporters. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside key references and suggestions for further reading. The landscape format of the Concise Guide is designed to facilitate comparison of related targets from material contemporary to mid‐2021, and supersedes data presented in the 2019/20, 2017/18, 2015/16 and 2013/14 Concise Guides and previous Guides to Receptors and Channels. It is produced in close conjunction with the Nomenclature and Standards Committee of the International Union of Basic and Clinical Pharmacology (NC‐IUPHAR), therefore, providing official IUPHAR classification and nomenclature for human drug targets, where appropriate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anaerobic degradation of monoaromatic hydrocarbons
Chakraborty, R., & Coates, J. D. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-003-1526-x · Cited by 251
The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients
Kalus, P., Muller, T. J., Zuschratter, W., & Senitz, D. (2000) · NeuroReport · doi:10.1097/00001756-200011090-00044 · Cited by 146
Visual and circadian responses to light in aged retinally degenerate mice
Provencio, I., Wong, S., Lederman, A. B., Argamaso, S. M., & Foster, F. (1994) · Vision Research · doi:10.1016/0042-6989(94)90304-2 · Cited by 135
Biochemical and behavioral studies of the 5‐HT1B receptor agonist, CP‐94,253
Koe, B. K., Nielsen, J. A., Macor, J. E., & Heym, J. H. (1992) · Drug Development Research · doi:10.1002/ddr.430260305 · Cited by 109
Antipsychotic drugs, dopamine receptors, and schizophrenia
Seeman, P. M. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00007-4 · Cited by 77
M871—A Novel Peptide Antagonist Selectively Recognizing the Galanin Receptor Type 2
Sollenberg, U. E., Lundström, L., Bartfai, T., & Langel, Ü. (2006) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-005-9008-x · Cited by 59
Theories that explain the social lazing
Anei, D. A. (2010) · Maǧallaẗ ǧāmiʻaẗ al-Anbār li-l-ʻulūm al-insāniyyaẗ/Maǧallaẗ ǧāmiʻaẗ al-anbār li-l-ʻulūm al-insāniyyaẗ · doi:10.37653/juah.2010.14547 · Cited by 6
Tanaka, Y., Nakamura, K., & Kurasawa, M. (1998) · Drug Development Research · doi:10.1002/(sici)1098-2299(199808)44:4<140::aid-ddr2>3.0.co;2-r · Cited by 4
Evaluación del impacto de la propaganda de Al Qaeda sobre la opinión pública musulmana
Soriano, M. R. T. (2009) · Inteligencia y Seguridad · doi:10.5211/iys.7.article10 · Cited by 4
Cited by
Community guidelines for GPCR ligand bias: IUPHAR review 32
Kolb, P., Kenakin, T., Alexander, S. P. H., Bermudez, M., Bohn, L. M., Breinholt, C. S., Bouvier, M., Hill, S. J., Kostenis, E., Martemyanov, K. A., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15811 · Cited by 232
Small interfering RNA: Discovery, pharmacology and clinical development—An introductory review
Ranasinghe, P., Addison, M. L., Dear, J. W., & Webb, D. J. (2023) · British Journal of Pharmacology · doi:10.1111/bph.15972 · Cited by 138
Kabahizi, A., Wallace, B., Lieu, L., Chau, D., Dong, Y., Hwang, E., & Williams, K. W. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15682 · Cited by 126
Roussin, A., Soeiro, T., Fouque, C., Jouanjus, E., Frauger, E., Fouilhé, N., Mallaret, M., Micallef, J., Lapeyre‐Mestre, M., & the French Addictovigilance Network (FAN) (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15323 · Cited by 38
A GLP‐1/glucagon (GCG)/CCK2 receptors tri‐agonist provides new therapy for obesity and diabetes
Zhao, S., Yan, Z., Du, Y., Li, Z., Tang, C., Jing, L., Sun, L., Yang, Q., Tang, X., Yuan, Y., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15860 · Cited by 30
Metadata
- Authors
- Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., Southan, C., Davies, J. A., Abbracchio, M. P., Alexander, W., Al‐hosaini, K., Bäck, M., Barnes, N. M., Bathgate, R., Beaulieu, J., Bernstein, K. E., Bettler, B., Birdsall, N. J. M., Blaho, V., Boulay, F., Bousquet, C., Bräuner‐Osborne, H., Burnstock, G., Caló, G., Castaño, J. P., Catt, K. J., Ceruti, S., Chazot, P., Chiang, N., Chini, B., Chun, J., Cianciulli, A., Civelli, O., Clapp, L. H., Couture, R., Csaba, Z., Dahlgren, C., Dent, G., Singh, K. D., Douglas, S. D., Dournaud, P., Eguchi, S., Escher, E., Filardo, E. J., Fong, T., Fumagalli, M., Gainetdinov, R. R., Gasparo, M. D., Gerard, C., Gershengorn, M., Gobeil, F., Goodfriend, T. L., Goudet, C., Gregory, K. J., Gundlach, A. L., Hamann, J., Hanson, J., Hauger, R. L., Hay, D. L., Heinemann, A., Hollenberg, M. D., Holliday, N. D., Horiuchi, M., Hoyer, D., Hunyady, L., Husain, A., IJzerman, A. P., Inagami, T., Jacobson, K. A., Jensen, R. T., Jockers, R., Jonnalagadda, D., Karnik, S., Kaupmann, K., Kemp, J., Kennedy, C., Kihara, Y., Kitazawa, T., Kozielewicz, P., Kreienkamp, H., Kukkonen, J. P., Langenhan, T., Leach, K., Lecca, D., Lee, J. D., Leeman, S. E., Leprince, J., Li, X. X., Williams, T. L., Lolait, S. J., Lupp, A., Macrae, R., Maguire, J., Mazella, J., McArdle, C. A., Melmed, S., Michel, M. C., Miller, L. J., Mitolo, V., Mouillac, B., Müller, C. E., Murphy, P., Nahon, J., Ngo, T., Norel, X., Nyimanu, D., O’Carroll, A., Offermanns, S., Panaro, M. A., Parmentier, M., Pertwee, R. G., Pin, J., Prossnitz, E. R., Quinn, M., Ramachandran, R., Ray, M., Reinscheid, R. K., Rondard, P., Rovati, G. E., Ruzza, C., Sanger, G. J., Schöneberg, T., Schulte, G., Schulz, S., Segaloff, D. L., Serhan, C. N., Stoddart, L. A., Sugimoto, Y., Summers, R., Tan, V. P., Thal, D., Thomas, W. (., Timmermans, P. B. M. W. M., Tirupula, K., Tulipano, G., Unal, H., Unger, T., Valant, C., Vanderheyden, P., Vaudry, D., Vaudry, H., Vilardaga, J., Walker, C. S., Wang, J. M., Ward, D. T., Wester, H., Willars, G. B., Woodruff, T. M., Yao, C., & Ye, R. D.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2021-09-16
- Volume
- 178
- Issue
- S1
- Pages
- S27-S156
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W3199710005
- Cited by
- 484
- References
- 9
- FWCI
- 29.85
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.